A Bridge between Pharmacovigilance Tools and Clinical Practice
Versandkostenfrei!
Versandfertig in 6-10 Tagen
24,99 €
inkl. MwSt.
PAYBACK Punkte
12 °P sammeln!
Our study is the first to utilize the OpenVigil 2.1, a universal novel web-based pharmacovigilance analysis tool to analyze real-life safety and effectiveness of six ADHD medications with special emphasis on psychiatric adverse events. We accounted for the following ADHD medications; atomoxetine, lisdexamphetamine, amphetamine, methylphenidate (instant release, intermediate acting, long acting). We believe that thorough knowledge of adverse events for each medication helps to support treatment guidelines and clinical management of the events.
Andere Kunden interessierten sich für
